StockGlow

DarioHealth Corp. (DRIO)

Provides AI-coached digital health app for managing diabetes, hypertension, weight, and mental health

$7.50+0.00%Healthcare
Compare DRIO with
StockGlow Score
58
Neutral
BearishBullish
1 year ago-31.9%

The outlook

DRIO trades near its 52-week lows with analyst coverage showing strong buy consensus and an average price target roughly double the current price. The stock sits mixed against its moving averages, reflecting choppy near-term price action despite the bullish analyst lean.

What’s behind the score

Analyst consensusStrong Buy — 1.5 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range14% of the way from its 52-week low to high
Price targetAvg target +103% vs current price

Analyst price target

~12-month · 4 analysts
$15.25average target+103.5% vs now
Now $7.50
Low $10.00High $28.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$54.8M
52-wk high
$17.74
52-wk low
$5.85
50-day avg
$7.25
200-day avg
$9.94
Trailing P/E
—

Similar stocks

PAVMPAVmed Inc.$5.38+3.46%CLPTClearPoint Neuro, Inc.$14.53-0.48%MYOMyomo, Inc.$0.96-9.91%CTSOCytosorbents Corporation$0.37+2.78%XBIOXenetic Biosciences, Inc.$2.50+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy